LiGHT Trial Shows SLT More Effective
Filed with ASX · · 3 pages · English
Earlier from Nova Eye Medical
- Investor Presentation FY2019 H1
- Sales Update at AGM
- 2018 CEO AGM Presentation
- Ellex 2RT Sales & Marketing Initiatives at AAO
- ELX LEAD trial investor presentation
Later from Nova Eye Medical
- Ellex Appoints Gerard Wallace as CEO
- Investor Presentation May 2019
- Lead Shows Positive 2RT Benefits in iAMD Patients at 4 Years
- Appointment of Interim CEO and trading update
- ELX FY19 ASX Release & Investor Presentation
Follow Nova Eye Medical into a list and get an email when it puts out news.
Follow Nova Eye Medical